ArticleDiscover oncology2025
Mediating factors between autoimmune thyroiditis and breast cancer: a bidirectional Mendelian randomization study.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe association between autoimmune thyroiditis (AIT) and breast cancer was still confused and the mediators was not cleared. In this study, we designed to search a probably causality and mediators between AIT and breast cancer.
methodWe adopted a bidirectional Mendelian Randomization (MR) analysis to explore the causal association and the potential mediating effects. We used Genome-Wide Association Studies (GWAS) data to construct instrumental variables. We extracted single nucleotide polymorphisms (SNPs) which were significantly associated with exposure factors and the significance threshold was set at p < 1.0 × 10
resultsWhen AIT was exposed, all the methods indicated that AIT increased the risk of breast cancer (OR values were all > 1 and P < 0.05). When breast cancer was exposed, no significant result was found. Single-factor MR analysis was used for 1400 metabolites and 211 gut microbiome, and showed AIT has a significant causal relationship with 7-methylxanthine IVW: (95% CI 0.001-0.059; p = 0.039). In reverse, there was no causality. 7-Methylxanthine has a causal relationship with breast cancer (95% CI 1.032-1.203; p = 0.006). Multi-factor MR analysis was adopted by adding of 7-methylxanthine to AIT on Breast cancer, the result was still significant, the AIT IVW (95% CI 0.007-0.055; p = 0.011), 7-methylxanthine IVW (95% CI 0.031-0.200; P = 0.007).
conclusionAIT can increase the risk of breast cancer, there is no causal link in the reverse direction. Among the 1400 metabolites, 7-methylxanthine is a mediator of AIT to breast cancer. There were no mediators from AIT to breast cancer in the 211 gut microbiome taxa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.